The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 biomarker trial of combination cediranib and olaparib in relapsed platinum (plat) sensitive and plat resistant ovarian cancer (ovca).
 
Joyce F. Liu
Consulting or Advisory Role - AstraZeneca; Tesaro
Research Funding - Acetylon Pharmaceuticals (Inst); Agenus (Inst); AstraZeneca (Inst); Atara Biotherapeutics (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); CytomX Therapeutics (Inst); Genentech/Roche (Inst); Merrimack (Inst)
 
William Thomas Barry
Research Funding - Pfizer (Inst)
Other Relationship - ARMO BioSciences
 
Robert Michael Wenham
Stock and Other Ownership Interests - Ovation Diagnostics
Honoraria - Clovis Oncology; Tesaro
Consulting or Advisory Role - Clovis Oncology; Genentech; Ovation Diagnostics; Tesaro
Speakers' Bureau - Clovis Oncology; Genentech; Tesaro
Research Funding - Merck (Inst); TapImmune Inc. (Inst)
 
Andrea Elisabeth Wahner Hendrickson
No Relationships to Disclose
 
Deborah Kay Armstrong
Honoraria - AstraZeneca/MedImmune
Consulting or Advisory Role - CUE Biopharma
Research Funding - Advaxis (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Eisai (I); Exelixis (I); Medpace (Inst); Pfizer (Inst); Syndax (Inst); Tesaro (Inst)
 
Nancy Chan
No Relationships to Disclose
 
David E. Cohn
Consulting or Advisory Role - Oncolytics
Research Funding - Oncolytics (Inst)
 
Jung-min Lee
No Relationships to Disclose
 
Richard T. Penson
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - AstraZeneca
 
Mihaela C. Cristea
No Relationships to Disclose
 
James L. Abbruzzese
Honoraria - AstraZeneca; Celgene; Fujifilm; Halozyme; Sun Pharma
Consulting or Advisory Role - Bessor Pharma; Celgene; EMD Serono; Fujifilm; Halozyme; Sun Biopharma
 
KOJI MATSUO
No Relationships to Disclose
 
Alexander Olawaiye
Consulting or Advisory Role - plasma surgical
 
Sarah Farooq
Employment - Takeda (I)
Stock and Other Ownership Interests - AVEO (I); Novartis (I); Orexigen (I); Seres Therapeutics (I); ZIOPHARM Oncology (I)
 
Elizabeth M. Swisher
No Relationships to Disclose
 
Eliezer Mendel Van Allen
Stock and Other Ownership Interests - Genome Medical; Syapse; Tango Therapeutics
Consulting or Advisory Role - Genome Medical; InVitae; Novartis; Roche; Syapse; Takeda; Third Rock Ventures
Speakers' Bureau - Illumina
Research Funding - Bristol-Myers Squibb; Novartis
 
Geoffrey Shapiro
Consulting or Advisory Role - G1 Therapeutics; Lilly; Merck Serono; Pfizer; Roche; Sierra Oncology
Research Funding - Aileron Therapeutics (Inst); AstraZeneca (Inst); Bayer (Inst); CanBas (Inst); Cellceutix (Inst); Covidien (Inst); Curis (Inst); Cyclacel (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immune Design (Inst); Lilly; Lilly (Inst); Merck Serono; Millennium (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); PTC Therapeutics (Inst); Puma Biotechnology (Inst); Roche (Inst); Sanofi (Inst); Sierra Oncology; Syros Pharmaceuticals (Inst); Tensha Therapeutics (Inst); Tesaro (Inst); Vertex (Inst)
 
Elise C. Kohn
No Relationships to Disclose
 
S. Percy Ivy
No Relationships to Disclose
 
Ursula A. Matulonis
Consulting or Advisory Role - 2X Oncology; Clovis Oncology; Fujifilm; Geneos; Lilly; Merck; Myriad Genetics
Research Funding - Merck; Novartis